Thelansis

  Alagille syndrome (ALGS) is a rare genetic disorder that can affect multiple body organ systems, including the heart, eyes, skeleton, liver, and kidneys. Alagille syndrome symptoms and severity can vary from person to person, even within the same family. Some people may have a mild form of the disorder that goes unnoticed; others may have a severe form of the disorder that can potentially cause life-threatening complications. Individuals with Alagille syndrome may experience jaundice and cholestasis during their first four months of life. Alagille syndrome incidence has been estimated to be 2 to 3 cases in every 100,000 population. Thelansis’s “Alagille Syndrome (ALGS) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key ma...